Keywords: anergen, immune, therapy, diabetes, presented, preclinical, data

Anergen Immune Therapy For Diabetes

Article | 27 November 1995

Anergen has presented preclinical data which demonstrate the effectiveness of its IDDM-AnergiX drug in an animal model of insulin-dependent diabetes ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novo Nordisk

Go to company listing

Related Drugs

Humulin 70-30

Insulin

Humulin N

Humulin R

Go to drug listing